Effects of rIL-12 administration on an antigen specific immune response.
Rempel-Chin
J D
JD
Department of Immunology, University of Manitoba, Winnipeg, Canada.
Wang
M D
MD
HayGlass
K T
KT
D000818:Animals; D000941:Antigens / Q000276:immunology; D007073:Immunoglobulin E / Q000096:biosynthesis*; D007074:Immunoglobulin G / Q000096:biosynthesis*; D007371:Interferon-gamma / Q000096:biosynthesis*; D016753:Interleukin-10 / Q000096:biosynthesis*; D018664:Interleukin-12 / Q000008:administration & dosage*; D015847:Interleukin-4 / Q000096:biosynthesis*; D051379:Mice; D008810:Mice, Inbred C57BL; D010047:Ovalbumin / Q000276:immunology; D011994:Recombinant Proteins / Q000008:administration & dosage; D014614:Vaccines, Synthetic / Q000008:administration & dosage*
D000941:Antigens; D007074:Immunoglobulin G; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D016753:Interleukin-10; D018664:Interleukin-12; D015847:Interleukin-4; D007073:Immunoglobulin E; D007371:Interferon-gamma; D010047:Ovalbumin